| Literature DB >> 158700 |
Abstract
The use of tetrabenazine to treat the movement disorder of Huntington's chorea and other dyskinesias is described. Tetrabenazine produced moderate to marked improvement in the movement disorder in 79% of a series of 40 Australian patients. The most commonly reported side effects were depression, drowsiness and Parkinsonism.Entities:
Mesh：
Substances：
Year: 1979 PMID： 158700 DOI： 10.5694/j.1326-5377.1979.tb119426.x
Source DB: PubMed Journal: Med J Aust ISSN： 0025-729X Impact factor: 7.738